{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T17:15:42Z","timestamp":1794158142866,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mater Sci: Mater Med"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10856-019-6226-x","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T11:21:42Z","timestamp":1549970502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Raman spectroscopy as a predictive tool for monitoring osteoporosis therapy in a rat model of postmenopausal osteoporosis"],"prefix":"10.1007","volume":"30","author":[{"given":"J. Renwick","family":"Beattie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Sophocleous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Clare","family":"Caraher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olive","family":"O\u2019Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh M.","family":"Cummins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E. J.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Towler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Rahimnejad Yazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart H.","family":"Ralston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymen I.","family":"Idris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,12]]},"reference":[{"key":"6226_CR1","doi-asserted-by":"publisher","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785\u201395. \n                    https:\/\/doi.org\/10.1001\/jama.285.6.785","DOI":"10.1001\/jama.285.6.785"},{"key":"6226_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00198-005-2035-9","volume":"17","author":"S Viguet-Carrin","year":"2006","unstructured":"Viguet-Carrin S, Garnero P, Delmas PD. The role of collagen in bone strength. Osteoporos Int. 2006;17:319\u201336. \n                    https:\/\/doi.org\/10.1007\/s00198-005-2035-9","journal-title":"Osteoporos Int"},{"key":"6226_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3233\/SPE-2010-0471","volume":"24","author":"NM Cummins","year":"2010","unstructured":"Cummins NM, Day JCC, Wren A, Carroll P, Murphy N, Jakeman PM et al. Raman spectroscopy of fingernails: a novel tool for evaluation of bone quality? Spectroscopy. 2010;24:517\u201324. \n                    https:\/\/doi.org\/10.3233\/SPE-2010-0471","journal-title":"Spectroscopy"},{"key":"6226_CR4","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10856-006-0018-9","volume":"18","author":"MR Towler","year":"2007","unstructured":"Towler MR, Wren A, Rushe N, Saunders J, Cummins NM, Jakeman PM. Raman spectroscopy of the human nail: a potential tool for evaluating bone health? J Mater Sci Mater Med. 2007;18:759\u201363. \n                    https:\/\/doi.org\/10.1007\/s10856-006-0018-9","journal-title":"J Mater Sci Mater Med"},{"key":"6226_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10856-006-0037-6","volume":"18","author":"P Moran","year":"2007","unstructured":"Moran P, Towler MR, Chowdhury S, Saunders J, German MJ, Lawson NS et al. Preliminary work on the development of a novel detection method for osteoporosis. J Mater Sci Mater Med. 2007;18:969\u201374. \n                    https:\/\/doi.org\/10.1007\/s10856-006-0037-6","journal-title":"J Mater Sci Mater Med"},{"key":"6226_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1089\/jwh.2005.14.339","volume":"14","author":"I Pillay","year":"2005","unstructured":"Pillay I, Lyons D, German MJ, Lawson NS, Pollock HM, Saunders J et al. The use of fingernails as a means of assessing bone health: a pilot study. J Women\u2019s Health (Larchmt). 2005;14:339\u201344. \n                    https:\/\/doi.org\/10.1089\/jwh.2005.14.339","journal-title":"J Women\u2019s Health (Larchmt)"},{"key":"6226_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4137\/CMAMD.S38493","volume":"9","author":"JR Beattie","year":"2016","unstructured":"Beattie JR, Cummins NM, Caraher C, O\u2019Driscoll OM, Bansal AT, Eastell R et al. Raman spectroscopic analysis of fingernail clippings can help differentiate between postmenopausal women who have and have not suffered a fracture. Clin Med Insights Arthritis Musculoskelet Disord. 2016;9:109\u201316. \n                    https:\/\/doi.org\/10.4137\/CMAMD.S38493","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"6226_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/jrs.5123","volume":"48","author":"JR Beattie","year":"2017","unstructured":"Beattie JR, Caraher MC, Cummins NM, O\u2019Driscoll OM, Eastell R, Ralston SH et al. Raman spectral variation for human fingernails of postmenopausal women is dependent on fracture risk and osteoporosis status. J Raman Spectrosc. 2017;48:813\u201321. \n                    https:\/\/doi.org\/10.1002\/jrs.5123","journal-title":"J Raman Spectrosc"},{"key":"6226_CR9","doi-asserted-by":"publisher","first-page":"117954411775405","DOI":"10.1177\/1179544117754050","volume":"11","author":"JR Beattie","year":"2018","unstructured":"Beattie JR, Feskanich D, Caraher MC, Towler MR. A preliminary evaluation of the ability of keratotic tissue to act as a prognostic indicator of hip fracture risk. Clin Med Insights Arthritis Musculoskelet Disord. 2018;11:117954411775405 \n                    https:\/\/doi.org\/10.1177\/1179544117754050","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"6226_CR10","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.bbadis.2017.10.020","volume":"1864","author":"MC Caraher","year":"2018","unstructured":"Caraher MC, Sophocleous A, Beattie JR, O\u2019Driscoll O, Cummins NM, Brennan O et al. Raman spectroscopy predicts the link between claw keratin and bone collagen structure in a mouse model of oestrogen deficiency. Biochim Biophisica Acta Mol Basis Dis. 2018;1864:398\u2013406.","journal-title":"Biochim Biophisica Acta Mol Basis Dis"},{"key":"6226_CR11","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1210\/jc.2006-2758","volume":"92","author":"O Bruyere","year":"2007","unstructured":"Bruyere O, Roux C, Detilleux J, Slosman DO, Spector TD, Fardellone P et al. Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J Clin Endocrinol Metab. 2007;92:3076\u201381. \n                    https:\/\/doi.org\/10.1210\/jc.2006-2758","journal-title":"J Clin Endocrinol Metab"},{"key":"6226_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0002-9343(01)01124-X","volume":"112","author":"SR Cummings","year":"2002","unstructured":"Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ et al. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med. 2002;112:281\u20139. \n                    https:\/\/doi.org\/10.1016\/S0002-9343(01)01124-X","journal-title":"Am J Med"},{"key":"6226_CR13","doi-asserted-by":"publisher","first-page":"10022","DOI":"10.1073\/pnas.0702254104","volume":"104","author":"RT Guo","year":"2007","unstructured":"Guo R-T, Cao R, Liang P-H, Ko T-P, Chang T-H, Hudock MP et al. Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases. Proc Natl Acad Sci USA. 2007;104:10022\u20137. \n                    https:\/\/doi.org\/10.1073\/pnas.0702254104","journal-title":"Proc Natl Acad Sci USA"},{"key":"6226_CR14","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","volume":"333","author":"UA Liberman","year":"1995","unstructured":"Liberman UA, Weiss SR, Br\u00f6ll J, Minne HW, Quan H, Bell NH et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med. 1995;333:1437\u201344. \n                    https:\/\/doi.org\/10.1056\/NEJM199511303332201","journal-title":"N Engl J Med"},{"key":"6226_CR15","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1210\/jcem.85.11.6953","volume":"85","author":"DM Black","year":"2000","unstructured":"Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC et al. Fracture risk reduction with alendronate in women with osteoporosis: the fracture intervention trial. J Clin Endocrinol Metab. 2000;85:4118\u201324. \n                    https:\/\/doi.org\/10.1210\/jcem.85.11.6953","journal-title":"J Clin Endocrinol Metab"},{"key":"6226_CR16","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","volume":"348","author":"DM Black","year":"1996","unstructured":"Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet. 1996;348:1535\u201341. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(96)07088-2","journal-title":"Lancet"},{"key":"6226_CR17","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","volume":"280","author":"SR Cummings","year":"1998","unstructured":"Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the fracture intervention trial. JAMA. 1998;280:2077 \n                    https:\/\/doi.org\/10.1001\/jama.280.24.2077","journal-title":"JAMA"},{"key":"6226_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.7326\/0003-4819-122-1-199501010-00002","volume":"122","author":"JA Cauley","year":"1995","unstructured":"Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women. Ann Intern Med. 1995;122:9 \n                    https:\/\/doi.org\/10.7326\/0003-4819-122-1-199501010-00002","journal-title":"Ann Intern Med"},{"key":"6226_CR19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1590\/S0482-50042011000400008","volume":"51","author":"DK Khajuria","year":"2011","unstructured":"Khajuria DK, Razdan R, Mahapatra DR. Drugs for the management of osteoporosis: a review. Rev Bras Reumatol. 2011;51:372\u201382. \n                    https:\/\/doi.org\/10.1590\/S0482-50042011000400008","journal-title":"Rev Bras Reumatol"},{"key":"6226_CR20","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1080\/13543784.2017.1371136","volume":"26","author":"AD Dede","year":"2017","unstructured":"Dede AD, Makras P, Anastasilakis AD. Investigational anabolic agents for the treatment of osteoporosis: an update on recent developments. Expert Opin Investig Drugs. 2017;26:1137\u201344. \n                    https:\/\/doi.org\/10.1080\/13543784.2017.1371136","journal-title":"Expert Opin Investig Drugs"},{"key":"6226_CR21","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster J-Y et al. Effect of parathyroid Hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344:1434\u201341. \n                    https:\/\/doi.org\/10.1056\/NEJM200105103441904","journal-title":"N Engl J Med"},{"key":"6226_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1590\/S1516-31802008000500007","volume":"126","author":"VFM Trevisani","year":"2008","unstructured":"Trevisani VFM, Riera R, Imoto AM, Saconato H, Atallah \u00c1N. Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review. Sao Paulo Med J. 2008;126:279\u201384. \n                    https:\/\/doi.org\/10.1590\/S1516-31802008000500007\n                    \n                  .","journal-title":"Sao Paulo Med J"},{"key":"6226_CR23","doi-asserted-by":"publisher","unstructured":"A Sophocleous, AI Idris, Rodent models of osteoporosis, Bonekey Rep. 3 (2014). \n                    https:\/\/doi.org\/10.1038\/bonekey.2014.109","DOI":"10.1038\/bonekey.2014.109"},{"key":"6226_CR24","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/jrs.2851","volume":"42","author":"JR Beattie","year":"2011","unstructured":"Beattie JR. Optimising reproducibility in low quality signals without smoothing; an alternative paradigm for signal processing. J Raman Spectrosc. 2011;42:1419\u201327. \n                    https:\/\/doi.org\/10.1002\/jrs.2851","journal-title":"J Raman Spectrosc"},{"key":"6226_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/jrs.4178","volume":"44","author":"JR Beattie","year":"2013","unstructured":"Beattie JR, McGarvey JJ. Estimation of signal backgrounds on multivariate loadings improves model generation in face of complex variation in backgrounds and constituents. J Raman Spectrosc. 2013;44:329\u201338. \n                    https:\/\/doi.org\/10.1002\/jrs.4178","journal-title":"J Raman Spectrosc"},{"key":"6226_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/jrs.2146","volume":"40","author":"JR Beattie","year":"2009","unstructured":"Beattie JR, Glenn JV, Boulton ME, Stitt AW, McGarvey JJ. Effect of signal intensity normalization on the multivariate analysis of spectral data in complex \u201creal-world\u201d datasets. J Raman Spectrosc. 2009;40:429\u201335. \n                    https:\/\/doi.org\/10.1002\/jrs.2146","journal-title":"J Raman Spectrosc"},{"key":"6226_CR27","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/jrs.2896","volume":"42","author":"J Palack\u00fd","year":"2011","unstructured":"Palack\u00fd J, Mojze\u0161 P, Bok J. SVD-based method for intensity normalization, background correction and solvent subtraction in Raman spectroscopy exploiting the properties of water stretching vibrations. J Raman Spectrosc. 2011;42:1528\u201339. \n                    https:\/\/doi.org\/10.1002\/jrs.2896","journal-title":"J Raman Spectrosc"},{"key":"6226_CR28","doi-asserted-by":"publisher","unstructured":"Mandair GS, Esmonde-White FWL, Akhter MP, Swift AM, Kreider J, Goldstein SA et al. Potential of Raman spectroscopy for evaluation of bone quality in osteoporosis patients: results of a prospective study, In: Kollias N, Choi B, Zeng H, Malek RS, Wong BJ, Ilgner JFR (eds). USA: International Society for Optics and Photonics; 2010: p. 754846. \n                    https:\/\/doi.org\/10.1117\/12.842515","DOI":"10.1117\/12.842515"},{"key":"6226_CR29","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.bone.2005.02.012","volume":"36","author":"G Penel","year":"2005","unstructured":"Penel G, Delfosse C, Descamps M, Leroy G. Composition of bone and apatitic biomaterials as revealed by intravital Raman microspectroscopy. Bone. 2005;36:893\u2013901. \n                    https:\/\/doi.org\/10.1016\/j.bone.2005.02.012","journal-title":"Bone"},{"key":"6226_CR30","doi-asserted-by":"publisher","unstructured":"Campbell GM, Sophocleous A, Quantitative analysis of bone and soft tissue by micro-computed tomography: applications to ex vivo and in vivo studies, Bonekey Rep. 3 (2014). \n                    https:\/\/doi.org\/10.1038\/bonekey.2014.59","DOI":"10.1038\/bonekey.2014.59"},{"key":"6226_CR31","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s00198-004-1725-z","volume":"16","author":"SE Papapoulos","year":"2005","unstructured":"Papapoulos SE, Quandt SA, Liberman UA, Hochberg MC, Thompson DE. Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women. Osteoporos Int. 2005;16:468\u201374. \n                    https:\/\/doi.org\/10.1007\/s00198-004-1725-z","journal-title":"Osteoporos Int"},{"key":"6226_CR32","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/J.FERTNSTERT.2009.02.093","volume":"92","author":"R Lindsay","year":"2009","unstructured":"Lindsay R, Gallagher JC, Kagan R, Pickar JH, Constantine G. Efficacy of tissue-selective estrogen complex of bazedoxifene\/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women. Fertil Steril. 2009;92:1045\u201352. \n                    https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2009.02.093","journal-title":"Fertil Steril"},{"key":"6226_CR33","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.1210\/jc.2003-030768","volume":"88","author":"AB Hodsman","year":"2003","unstructured":"Hodsman AB, Hanley DA, Ettinger MP, Bolognese MA, Fox J, Metcalfe AJ et al. Efficacy and safety of human parathyroid Hormone-(1\u201384) in increasing bone mineral density in postmenopausal osteoporosis. J Clin Endocrinol Metab. 2003;88:5212\u201320. \n                    https:\/\/doi.org\/10.1210\/jc.2003-030768","journal-title":"J Clin Endocrinol Metab"},{"key":"6226_CR34","doi-asserted-by":"publisher","unstructured":"Cosman F, Combination therapy for osteoporosis: a reappraisal, Bonekey Rep. 3 (2014). \n                    https:\/\/doi.org\/10.1038\/bonekey.2014.13","DOI":"10.1038\/bonekey.2014.13"},{"key":"6226_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00198-007-0533-7","volume":"19","author":"MR Allen","year":"2008","unstructured":"Allen MR, Gineyts E, Leeming DJ, Burr DB, Delmas PD. Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra. Osteoporos Int. 2008;19:329\u201337. \n                    https:\/\/doi.org\/10.1007\/s00198-007-0533-7","journal-title":"Osteoporos Int"},{"key":"6226_CR36","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1007\/s00198-010-1454-4","volume":"22","author":"M Saito","year":"2011","unstructured":"Saito M, Marumo K, Kida Y, Ushiku C, Kato S, Takao-Kawabata R et al. Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1\u201334) for 18 months contribute to improvement of bone strength in ovariectomized monkeys. Osteoporos Int. 2011;22:2373\u201383. \n                    https:\/\/doi.org\/10.1007\/s00198-010-1454-4","journal-title":"Osteoporos Int"},{"key":"6226_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00198-009-1066-z","volume":"21","author":"M Saito","year":"2010","unstructured":"Saito M, Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int. 2010;21:195\u2013214. \n                    https:\/\/doi.org\/10.1007\/s00198-009-1066-z","journal-title":"Osteoporos Int"},{"key":"6226_CR38","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S8756-3282(00)00376-8","volume":"27","author":"G Boivin","year":"2000","unstructured":"Boivin G, Chavassieux P, Santora A, Yates J, Meunier P. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone. 2000;27:687\u201394. \n                    https:\/\/doi.org\/10.1016\/S8756-3282(00)00376-8","journal-title":"Bone"},{"key":"6226_CR39","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00198-008-0725-9","volume":"20","author":"AL Boskey","year":"2009","unstructured":"Boskey AL, Spevak L, Weinstein RS. Spectroscopic markers of bone quality in alendronate-treated postmenopausal women. Osteoporos Int. 2009;20:793\u2013800. \n                    https:\/\/doi.org\/10.1007\/s00198-008-0725-9","journal-title":"Osteoporos Int"},{"key":"6226_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1138\/20060248","volume":"44","author":"MR Allen","year":"2007","unstructured":"Allen MR, Burr DB. Mineralization, microdamage, and matrix: how bisphosphonates influence material properties of bone. BoneKEy-Osteovision. 2007;44:49\u20136049. \n                    https:\/\/doi.org\/10.1138\/20060248","journal-title":"BoneKEy-Osteovision"},{"key":"6226_CR41","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00198-008-0754-4","volume":"20","author":"SY Tang","year":"2009","unstructured":"Tang SY, Allen MR, Phipps R, Burr DB, Vashishth D. Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. Osteoporos Int. 2009;20:887\u201394. \n                    https:\/\/doi.org\/10.1007\/s00198-008-0754-4","journal-title":"Osteoporos Int"},{"key":"6226_CR42","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1359\/jbmr.2003.18.6.955","volume":"18","author":"E Paschalis","year":"2003","unstructured":"Paschalis E, Boskey A, Kassem M, Eriksen E. Effect of hormone replacement therapy on bone quality in early postmenopausal women. J Bone Miner Res. 2003;18:955\u20139. \n                    https:\/\/doi.org\/10.1359\/jbmr.2003.18.6.955","journal-title":"J Bone Miner Res"},{"key":"6226_CR43","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/jbmr.1497","volume":"27","author":"MG Ascenzi","year":"2012","unstructured":"Ascenzi M-G, Liao VP, Lee BM, Billi F, Zhou H, Lindsay R et al. Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis. J Bone Miner Res. 2012;27:702\u201312. \n                    https:\/\/doi.org\/10.1002\/jbmr.1497","journal-title":"J Bone Miner Res"},{"key":"6226_CR44","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1007\/s11999-010-1692-y","volume":"469","author":"MD Morris","year":"2011","unstructured":"Morris MD, Mandair GS. Raman assessment of bone quality. Clin Orthop Relat Res. 2011;469:2160\u20139. \n                    https:\/\/doi.org\/10.1007\/s11999-010-1692-y","journal-title":"Clin Orthop Relat Res"},{"key":"6226_CR45","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1039\/b712389b","volume":"133","author":"E Widjaja","year":"2008","unstructured":"Widjaja E, Lim GH, An A. A novel method for human gender classification using Raman spectroscopy of fingernail clippings. Analyst. 2008;133:493 \n                    https:\/\/doi.org\/10.1039\/b712389b","journal-title":"Analyst"},{"key":"6226_CR46","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/jnci\/87.7.497","volume":"87","author":"M Garland","year":"1995","unstructured":"Garland M, Morris JS, Stampfer MJ, Colditz GA, Spate VL, Baskett CK et al. Prospective study of toenail selenium levels and cancer among women. JNCI J Natl Cancer Inst. 1995;87:497\u2013505. \n                    https:\/\/doi.org\/10.1093\/jnci\/87.7.497","journal-title":"JNCI J Natl Cancer Inst"},{"key":"6226_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1006\/ABIO.1999.4320","volume":"277","author":"JT Pelton","year":"2000","unstructured":"Pelton JT, McLean L. Spectroscopic methods for analysis of protein secondary structure. Anal Biochem. 2000;277:167\u201376. \n                    https:\/\/doi.org\/10.1006\/ABIO.1999.4320","journal-title":"Anal Biochem"}],"container-title":["Journal of Materials Science: Materials in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10856-019-6226-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-019-6226-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-019-6226-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:19:04Z","timestamp":1581466744000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10856-019-6226-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["6226"],"URL":"https:\/\/doi.org\/10.1007\/s10856-019-6226-x","relation":{},"ISSN":["0957-4530","1573-4838"],"issn-type":[{"value":"0957-4530","type":"print"},{"value":"1573-4838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"12 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"RB and MCC are former employees of Crescent Ops Ltd, a company which owns intellectual property on the relationship between Raman spectroscopy, nail structure and fracture risk. MT and RB are shareholders in Crescent Ops Ltd. MT, NC, OOD and RB have served as consultants for Crescent Ops Ltd. Crescent Diagnostics Ltd funded the work carried out by MCC, JRB, (OD), NMC, MT and SHR. AI and AS declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"25"}}